Co-Diagnostics said its joint venture in India, CoSara Diagnostics, has received clearance to manufacture and sell its Saraq Hepatitis C (HCV) Viral Load Kit as an in vitro diagnostic.
Co-Diagnostics said its joint venture in India, CoSara Diagnostics, has received clearance to manufacture and sell its Saraq Hepatitis C (HCV) Viral Load Kit as an in vitro diagnostic.
The company said the PCR-based test is built on CoSara's CoPrimer technology and aids in assessing response to antiviral treatments in patients diagnosed with HCV, which has no effective vaccine.
The clearance was granted by India's Central Drugs Standard Control Organization.
